Cooley Rx series
Life Sciences Litigation: Patent Litigation Damages Strategies, Trends and Legal Developments
Event summary
Cooley Rx is a virtual series focused on the life sciences and healthcare sectors. We discuss the top issues and trends in these industries – and provide decision-makers with information they can use to strengthen their organizations.
Life Sciences Litigation: Patent Litigation Damages Strategies, Trends and Legal Developments
Cooley life sciences litigation partners Betsy Flanagan and Orion Armon discussed:
- Recent trends in life sciences damages awards
- Drivers behind large damages awards
- Important developments in the law
- Prevalence and availability of injunctive relief
Credits
- Attendees may earn up to 1.0 CLE credit for participating in this live webinar. Credit will not be granted for on-demand viewing.
- Cooley LLP is an approved provider, and will provide credit in CA, CO, IL, NY, PA and TX.
- Cooley LLP is a sponsor, and will apply for credit in FL, OH, VA and WA.
- Credit in other jurisdictions may be available via reciprocity.
- If you have specific CLE credit questions, please contact Cooley’s licensing and compliance team.
For more information, please email Megan Senerchia.
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.